(secondQuint)T21,18 and 13 Screening by Cell Free Fetal DNA in Low Risk Patients.

 All pregnant women in 9 institutions in France will be offer both regular first trimester screening for trisomy 21 (T21) and cell free DNA non invasive (NI) screening test at the same time.

 Specificity and the positive and negative predictive values of the NI test will be analysed.

 The population will be divided in women who did and did not get pregnant after an In vitro fertilisation (IVF) procedure.

.

 T21,18 and 13 Screening by Cell Free Fetal DNA in Low Risk Patients@highlight

The purpose of this study is to evaluate the performance of non invasive screening in a population of pregnant women with and without in vitro fertilisation (IVF) concomitantly to regular first trimester trisomy 21 (T21) screening using maternal age, nucal fold measurement and serum screening.

